Influenza Vaccine Dose and Dementia Outcomes - Top-Institutions - MDSpire

Influenza Vaccine Dose and Dementia Outcomes

US claims data compare high- vs standard-dose formulations in patients aged 65 years or more over 3 years of follow-up

  • By

  • Kathryn Wighton

  • April 10, 2026

  • 3 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Geriatrics
    • Epidemiology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Geriatrics
    • Public Health

  • #3

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Geriatrics
    • Immunology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Geriatrics
    • Epidemiology

  • #5

    University of Washington
    University of Washington

    Seattle, WA

    Key Differentiators

    • Neurology
    • Geriatrics
    • Public Health

Original Source(s)

Influenza Vaccine Dose and Dementia Outcomes

  • by Kathryn Wighton

  • April 10, 2026

Related Content

Electroencephalographic abnormalities and clinical phenotypes in children with autism spectrum disorder: a single center cohort study

Association between triglyceride glucose-body mass index and outcomes in patients with acute ischemic stroke: a retrospective secondary analysis of a prospective Korean cohort

Global, regional, and national burden of disease for high BMI-related ischemic stroke in people aged 70 and older: trend analysis from 1990 to 2021 and projections for 2044